Moberg Pharma AB (publ) (MOB) — Cash Flow Quality Index
Moberg Pharma AB (publ) (MOB) has a Cash Flow Quality Index of -0.70x as of September 2019. Operating cash flow of Skr-29.30 Million is below net income of Skr41.76 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore MOB long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Moberg Pharma AB (publ) Cash Flow Quality Index (2012–2021)
Historical Cash Flow Quality Index for Moberg Pharma AB (publ) across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check MOB goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Moberg Pharma AB (publ) (2012–2021)
Year-by-year earnings quality comparison for Moberg Pharma AB (publ). For live market cap and the full company financial profile, see Moberg Pharma AB (publ) (MOB) total market value.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.04x | Skr-15.30 Million | Skr7.49 Million | ▼ -1134.5% |
| 2019 | 0.20x | Skr3.95 Million | Skr20.02 Million | ▼ -82.7% |
| 2018 | 1.14x | Skr73.89 Million | Skr64.82 Million | ▲ +8.2% |
| 2017 | 1.05x | Skr53.82 Million | Skr51.07 Million | ▲ +465.2% |
| 2016 | -0.29x | Skr-17.94 Million | Skr62.17 Million | ▼ -133.1% |
| 2015 | 0.87x | Skr30.72 Million | Skr35.18 Million | ▼ -6.9% |
| 2014 | 0.94x | Skr16.16 Million | Skr17.23 Million | ▲ +24.7% |
| 2012 | 0.75x | Skr9.48 Million | Skr12.59 Million | — |